Autism Spectrum Disorder

By B. Lo, Felicity Klopper, Elizabeth H Barnes, Katrina Jane Williams. 2018

3,985 citations recorded by the source corpus.

Subfields: Clinical Psychology, Cognitive Neuroscience, General Health Professions

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. Mayada Elsabbagh
2. Eric Fombonne
3. S. Robinson
4. Daniel H. Geschwind
5. E. Hill
6. C. Corsello
7. Shafali S. Jeste

In Cognitive Neuroscience

1. Jean-Pierre Changeux
2. Stanislas Dehaene
3. Zening Fu
4. Yuhui Du
5. Pieter R. Roelfsema
6. George A. Mashour
7. Qian Li
8. Yi Zhong

Citations in the corpus

• Genetic dissection of mutual interference between two consecutive learning tasks in Drosophila (2022, background): “Rac1 and Fmr1, which regulate Retro-I in Drosophila, are high-risk genes for autism (Lord et al., 2020).”
• Conscious Processing and the Global Neuronal Workspace Hypothesis (2020, positive): “The diverse drugs propofol (primarily GABAA receptor positive allosteric modulators), sevoflurane (strong GABAA agonism with diverse molecular targets), and ketamine (non-GABA anesthetic antagonizing NMDA receptors and HCN1 channels) have all been found by fMRI to functionally disconnect the PFC and”
• Global prevalence of autism: A systematic review update (2022, background): “Autism (or autism spectrum disorders, ASD) is defined on the basis of social and communication problems and repetitive and restrictive behaviors that can vary in individuals along a continuum of severity (Lord et al., 2018).”
• Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation (2020, background): “Ultimately, ASD remains one of the most genetically heterogeneous neuropsychiatric disorders with rarer de novo and inherited variants in over 700 genes (53).”
• Classification and Prediction of Brain Disorders Using Functional Connectivity: Promising but Challenging (2018, background): “…prevalence of 1:68 in the United States (Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control Prevention, 2012) and the lifetime costs of treating an American with ASD has exceeded one million dollars (Greenspan, 2015).”
• Abnormal Brain Connectivity Patterns in Children with Global Developmental Delay Accompanied by Cognitive Impairment: A Resting-State EEG Study. (2025, unknown): “Given that ASD and GDD are both neurodevelopmental disorders sharing similar etiologies, clinical manifestations, and imaging features [39,40].”